Adagio Medical Holdings (ADGM) Operating Income (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Operating Income data on file, last reported at -$5.2 million in Q1 2026.

• Operating Income for Q1 2026 came in at -$5.2 million, up 29.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.6 million (up 28.17% YoY), and the FY2025 annual result was -$21.9 million, up 64.96% from the prior year.
• Operating Income retreated to -$5.2 million in Q1 2026 per ADGM's latest filing, from -$4.0 million in the prior quarter.
• Over five years, Operating Income peaked at -$4.0 million in Q4 2025 and troughed at -$9.1 million in Q3 2023.
• A 4-year average of -$6.1 million and a median of -$5.5 million in 2023 frame the typical range for Operating Income.
• The sharpest annual moves came in 2024 and 2025: Operating Income jumped 51.27% in 2024, then retreated 29.29% in 2025.
• A 4-year view of Operating Income shows it stood at -$5.3 million in 2023, then grew by 17.03% to -$4.4 million in 2024, then rose by 10.33% to -$4.0 million in 2025, then slumped by 31.05% to -$5.2 million in 2026.
• Business Quant data shows ADGM's Operating Income at -$5.2 million in Q1 2026, -$4.0 million in Q4 2025, and -$5.7 million in Q3 2025.